Skip to main content
رجوع
Watch Compare

KORU Medical Systems, Inc.

جودة البيانات: 100%
KRMD
Nasdaq Manufacturing Measuring & Analyzing Instruments
KWD 4.34
▲ KWD 0.15 (3.58%)
القيمة السوقية: 201.25 M
السعر
KWD 4.34
القيمة السوقية
201.25 M
نطاق اليوم
KWD 4.00 — KWD 4.39
نطاق 52 أسبوعًا
KWD 2.08 — KWD 6.61
حجم التداول
722,902
فتح KWD 4.20
متوسط 50 يوم / 200 يوم
KWD 4.72
8.05% below
متوسط 50 يوم / 200 يوم
KWD 4.47
2.94% below

Quick Summary

النقاط الرئيسية

Revenue grew 15.03% annually over 5 years — strong growth
Generating 462,405.0 in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 7.20%

النمو

Revenue Growth (5Y)
15.03%
أعلى من متوسط القطاع (1.82%)
Revenue (1Y)22.23%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-15.99%
أعلى من متوسط القطاع (-53.41%)
ROIC-12.12%
Net Margin-6.41%
Op. Margin-7.23%

الأمان

Debt / Equity
N/A
Current Ratio2.48
Interest CoverageN/A

التقييم

PE (TTM)
-76.29
أقل من متوسط القطاع (-1.48)
P/B Ratio12.22
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -76.3 -1.5
P/B 12.2 1.6
ROE % -16.0 -53.4
Net Margin % -6.4 -41.5
Rev Growth 5Y % 15.0 1.8
D/E — 0.3

ETFs Holding This Stock

BRUSX BRUSX
0.29% weight
GISMX GISMX
0.02% weight
GSMRX GSMRX
0.02% weight
GMSMX GMSMX
0.02% weight
VVICX VVICX
0.01% weight
IRCIX IRCIX
0.01% weight
IRSIX IRSIX
0.01% weight
IIRSX IIRSX
0.01% weight
IRSSX IRSSX
0.01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 22.23% Revenue Growth (3Y) 20.09%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 15.03% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 41.13 M Net Income (TTM) -2.64 M
ROE -15.99% ROA -10.03%
Gross Margin 62.26% Operating Margin -7.23%
Net Margin -6.41% Free Cash Flow (TTM) 462,405.0
ROIC -12.12% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2.48
Interest Coverage N/A Asset Turnover 1.56
Working Capital 11.59 M Tangible Book Value 15.78 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -76.29 Forward P/E N/A
P/B Ratio 12.22 P/S Ratio 4.89
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 0.23%
Market Cap 201.25 M Enterprise Value 192.78 M
Per Share
EPS (Diluted TTM) -0.06 Revenue / Share 0.89
FCF / Share 0.01 OCF / Share 0.01
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion -17.53%
SBC-Adj. FCF -1.89 M Growth Momentum 7.20

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 41.13 M 33.65 M 28.52 M 27.90 M 23.49 M
Net Income -2.64 M -6.07 M -13.74 M -8.66 M -4.56 M
EPS (Diluted) -0.06 -0.13 -0.30 -0.19 -0.10
Gross Profit 25.60 M 21.33 M 16.71 M 15.37 M 13.77 M
Operating Income -2.97 M -6.45 M -10.27 M -10.78 M -7.03 M
EBITDA — — — — —
R&D Expenses 4.39 M 5.26 M 5.74 M 4.96 M 2.47 M
SG&A Expenses 23.38 M 21.63 M 20.37 M 20.61 M 17.86 M
D&A 810,500.0 888,473.0 870,390.0 587,137.0 463,130.0
Interest Expense — — — — —
Income Tax 21,890.0 2,893.0 3.97 M -2.01 M 1.80 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 28.20 M 27.22 M 28.46 M 42.33 M 41.29 M
Total Liabilities 11.15 M 10.40 M 8.11 M 11.01 M 4.79 M
Shareholders' Equity 17.05 M 16.81 M 20.35 M 31.33 M 36.50 M
Total Debt — — — — —
Cash & Equivalents 8.87 M 9.58 M 11.48 M 17.41 M 25.33 M
Current Assets 19.99 M 19.13 M 20.26 M 29.80 M 37.32 M
Current Liabilities 8.19 M 7.20 M 4.45 M 6.96 M 4.79 M